Esperion Therapeutics, Inc. Other Liabilities, Noncurrent in USD from Q4 2019 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary: Esperion Therapeutics, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2019 to Q3 2025.
Esperion Therapeutics, Inc. Other Liabilities, Noncurrent for the quarter ending September 30, 2025 was $7.44M.

Other Liabilities, Noncurrent, Quarterly (USD)

Other Liabilities, Noncurrent, YoY Quarterly Growth (%)

Esperion Therapeutics, Inc. Quarterly Other Liabilities, Noncurrent (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$7.44M			Sep 30, 2025	10-Q	2025-11-06
Q2 2025	$7.44M			Jun 30, 2025	10-Q	2025-08-13
Q4 2024	$0			Dec 31, 2024	10-Q	2025-11-06
Q4 2021	$0	-$1.29M	-100%	Dec 31, 2021	10-K	2022-02-22
Q3 2021	$1.29M	-$420K	-24.6%	Sep 30, 2021	10-Q	2021-11-02
Q2 2021	$1.29M			Jun 30, 2021	10-Q	2021-08-03
Q1 2021	$1.29M			Mar 31, 2021	10-Q	2021-05-04
Q4 2020	$1.29M	+$1.29M		Dec 31, 2020	10-K	2022-02-22
Q3 2020	$1.71M			Sep 30, 2020	10-Q	2020-11-02
Q4 2019	$0			Dec 31, 2019	10-K	2021-02-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.